Why is Shanghai MicroPort Endovascular MedTech Co., Ltd. ?
1
Positive results in Jun 26
- DIVIDEND PAYOUT RATIO(Y) Highest at 93.77%
- RAW MATERIAL COST(Y) Fallen by -1.83% (YoY)
- NET PROFIT(9M) Higher at CNY 456.32 MM
2
With ROE of 13.73%, it has a attractive valuation with a 2.52 Price to Book Value
- Over the past year, while the stock has generated a return of -18.85%, its profits have risen by 32.2% ; the PEG ratio of the company is 0.6
- At the current price, the company has a high dividend yield of 2
How much should you buy?
- Overall Portfolio exposure to Shanghai MicroPort Endovascular MedTech Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Shanghai MicroPort Endovascular MedTech Co., Ltd. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Shanghai MicroPort Endovascular MedTech Co., Ltd.
-20.38%
-0.68
31.21%
China Shanghai Composite
3.23%
0.23
14.72%
Quality key factors
Factor
Value
Sales Growth (5y)
19.56%
EBIT Growth (5y)
17.69%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.52
Sales to Capital Employed (avg)
0.31
Tax Ratio
15.11%
Dividend Payout Ratio
49.49%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
51.23%
ROE (avg)
16.77%
Valuation Key Factors 
Factor
Value
P/E Ratio
18
Industry P/E
Price to Book Value
2.52
EV to EBIT
14.05
EV to EBITDA
12.63
EV to Capital Employed
3.98
EV to Sales
6.15
PEG Ratio
0.57
Dividend Yield
2.04%
ROCE (Latest)
28.34%
ROE (Latest)
13.73%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
Technical Movement
10What is working for the Company
DIVIDEND PAYOUT RATIO(Y)
Highest at 93.77%
RAW MATERIAL COST(Y)
Fallen by -1.83% (YoY
NET PROFIT(9M)
Higher at CNY 456.32 MM
NET SALES(Q)
Highest at CNY 423.71 MM
OPERATING PROFIT(Q)
Highest at CNY 199.1 MM
-2What is not working for the Company
DEBT-EQUITY RATIO
(HY)
Highest at -50.84 %
Here's what is working for Shanghai MicroPort Endovascular MedTech Co., Ltd.
Net Profit
At CNY 456.32 MM has Grown at 73.24%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
Net Sales
Highest at CNY 423.71 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Net Sales
At CNY 423.71 MM has Grown at 22.05%
over average net sales of the previous four periods of CNY 347.17 MMMOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Operating Profit
Highest at CNY 199.1 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (CNY MM)
Net Profit
Higher at CNY 456.32 MM
than preceding 12 month period ended Jun 2026MOJO Watch
In the nine month period the company has already crossed sales of the previous twelve months
Net Profit (CNY MM)
Dividend Payout Ratio
Highest at 93.77%
in the last five yearsMOJO Watch
Company is distributing higher proportion of profits generated as dividend
DPR (%)
Raw Material Cost
Fallen by -1.83% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Shanghai MicroPort Endovascular MedTech Co., Ltd.
Debt-Equity Ratio
Highest at -50.84 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Footer loading






